Zorka Milovanović
- Oncology top 10%
- Cancer-related Molecular Pathways 5
-
- Immune Cell Function and Interaction 6
- T-cell and B-cell Immunology 4
-
- Thyroid Cancer Diagnosis and Treatment 11
-
- Lung Cancer Treatments and Mutations 4
- Brain Metastases and Treatment 3
-
- PI3K/AKT/mTOR signaling in cancer 9
-
- BRCA gene mutations in cancer 4
- Co-authors
- Nikola TanićRadan DžodićNasta TanićMilica NedeljkovićSrdjan NikolićZorica D. JuranićIvan MarkovićVladimir Jurišić
- Cited by
- OncologyCancer ResearchImmunology
- Journals
- Journal of Clinical Oncology (2 papers)SHILAP Revista de lepidopterología (2 papers)BMC Cancer (2 papers)
- Partner nations
- SerbiaJapanUnited States
In The Last Decade
Zorka Milovanović
52 papers receiving 698 citations
Peers
Comparison fields: 5 of 89
- Oncology 261
- Cancer Research 119
- Immunology 162
- Endocrinology, Diabetes and Metabolism 86
- Pulmonary and Respiratory Medicine 115
Countries citing papers authored by Zorka Milovanović
This map shows the geographic impact of Zorka Milovanović's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zorka Milovanović with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zorka Milovanović more than expected).
Fields of papers citing papers by Zorka Milovanović
This network shows the impact of papers produced by Zorka Milovanović. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zorka Milovanović. The network helps show where Zorka Milovanović may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Zorka Milovanović, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 8 | |
| 2 | 2022 | 3 | |
| 3 | 2021 | 44 | |
| 4 | Interlaboratory concordance in HER2 testing: Results of a Serbian ring-study. | 2020 | 4 |
| 5 | 2020 | 14 | |
| 6 | Promoter hypermethylation of p16, BRCA1 and RASSF1A genes in triple-negative breast cancer patients from Serbia. | 2019 | 12 |
| 7 | 2018 | 29 | |
| 8 | 2018 | 24 | |
| 9 | 2015 | 41 | |
| 10 | 2014 | 46 | |
| 11 | 2014 | 3 | |
| 12 | 2014 | 22 | |
| 13 | Incidence of brain metastases in early stage HER2 3+ breast cancer patients; is there a role for brain CT in asymptomatic patients? | 2012 | 11 |
| 14 | 2012 | 20 | |
| 15 | PTEN protein expression in postmenopausal steroid receptor positive early breast cancer patients treated with adjuvant tamoxifen. | 2011 | 5 |
| 16 | 2011 | 25 | |
| 17 | Brain metastases as late breast cancer relapse. Single institution experience and review of the literature. | 2009 | 1 |
| 18 | 2008 | 37 | |
| 19 | 2004 | 2 | |
| 20 | 2004 | 4 |
About Zorka Milovanović
Zorka Milovanović is a scholar working on Oncology, Endocrinology, Diabetes and Metabolism and Cancer Research, having authored 55 papers that have together received 707 indexed citations. Recurring topics across this work include Thyroid Cancer Diagnosis and Treatment (11 papers), PI3K/AKT/mTOR signaling in cancer (9 papers), Immune Cell Function and Interaction (6 papers), Cancer-related Molecular Pathways (5 papers), BRCA gene mutations in cancer (4 papers), Lung Cancer Treatments and Mutations (4 papers), T-cell and B-cell Immunology (4 papers) and Brain Metastases and Treatment (3 papers). The work is most often cited by research in Oncology (261 citations), Cancer Research (119 citations) and Immunology (162 citations). Zorka Milovanović has collaborated with scholars based in Serbia, Japan and United States. Frequent co-authors include Nikola Tanić, Radan Džodić, Nasta Tanić, Milica Nedeljković, Srdjan Nikolić, Zorica D. Juranić, Ivan Marković, Vladimir Jurišić, Ana Vuletić and Gordana Konjević. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and BMC Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.